Advanced NMR announced last week that it has canceled its proposedmerger with Advanced Mammography Systems, the breast MRI developerof which it owns a majority interest.Advanced NMR, of Wilmington, MA, had originally planned to bringAMS under its wing
Advanced NMR announced last week that it has canceled its proposedmerger with Advanced Mammography Systems, the breast MRI developerof which it owns a majority interest.
Advanced NMR, of Wilmington, MA, had originally planned to bringAMS under its wing because of capitalization issues at the subsidiary.AMS recently completed a private placement of $3 million worthof convertible debentures, however, enabling the unit to remainindependent. Proceeds from the debenture issue will be used toaccelerate the completion of product development for AdvancedMammography Systems' Aurora dedicated breast MRI scanner and tofund a global product launch of the machine.
The merger cancellation renders moot a class action shareholderlawsuit filed against Advanced NMR earlier this year seeking tostop the merger (SCAN 2/28/96). Advanced NMR will continue toown 61% of AMS.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.